Skip to main content

Neurological deterioration in adult phenylketonuria


A 28-year-old man with classical phenylketonuria had increased seizure frequency and rapidly progressive spasticity. There was a marked reduction of biogenic amine neutotransmitter metabolites in cerebrospinal fluid. Dietary therapy reduced serum phenylalanine levels, improved symptoms of hypertonicity, and cerebrospinal fluid neurotransmitter metabolites became normal. An adolescent male with classical phenylketonuria, treated by dietary restriction until age 6 years, was assessed for decreasing school performance at 18 years. Cerebrospinal fluid biogenic amine neurotransmitter metabolites were significantly reduced. Magnetic resonance imaging in both subjects showed multiple areas of increased signal intensity in cerebral white matter. Neuropathological changes in classical phenylketonuria have been characterized as a dysmyelinating or demyelinating process. Neurochemical studies show a defect in brain lipids and biogenic amine metabolism. In the past, dietary therapy was directed at reducing hyperphenylalaninaemia only during the first decade of life. This report, as well as other studies, indicates that dietary therapy should be lifelong in patients with classical phenylketonuria, in order to prevent progressive and insidious neurological deterioration in later life.

This is a preview of subscription content, access via your institution.


  • Alvord, E. C., Stevenson, L. D., Vogel, F. S. and Engle, R. L. Neuropathological findings in phenylpyruvic oligophrenia (phenylketonuria).J. Neuropath. Exp. Neurol. 9 (1950) 298–310

    PubMed  Google Scholar 

  • Butler, I. J., O'Flynn, M. E., Seifert, W. E. and Howell, R. R. Neurotransmitter defects and treatment of disorders of hyperphenylalaninemia.J. Pediatr. 98 (1981) 729–733

    PubMed  Google Scholar 

  • Crome, L., Tymms, V. and Woolf, L. I. A chemical investigation of the defects of myelination in phenylketonuria.J. Neurol. Neurosurg. Psychiat. 25 (1962) 143–148

    PubMed  Google Scholar 

  • Koopmans, R. A., Li, D. K. B., Grochowski, E., Cutler, P. J. and Paty, D. W. Benign versus chronic progressive multiple sclerosis: magnetic resonance imaging features.Ann. Neurol. 25 (1989) 74–81

    PubMed  Google Scholar 

  • Lou, H. C., Guttler, F., Lykkelund, C., Bruhn, P. and Niedwieser, A. Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents.Eur. J. Pediatr. 144 (1985) 17–20

    PubMed  Google Scholar 

  • McKean, C. M. The effect of high phenylalanine concentrations on serotonin and catecholamine metabolism in the human brain.Brain Res. 47 (1972) 469–476

    PubMed  Google Scholar 

  • Malamud, N. Neuropathology of phenylketonuria.J. Neuropath. Exp. Neurol. 25 (1966) 254–268

    PubMed  Google Scholar 

  • Neame, K. E. Phenylalanine as an inhibitor of transport of amino acids in brain.Nature (London) 192 (1961) 173–174

    Google Scholar 

  • Poser, C. M. and van Bogaert, L. Neuropathologic observations in phenylketonuria.Brain 82 (1959) 1–8

    PubMed  Google Scholar 

  • Pratt, O. E. Transport inhibition in the pathology of phenylketonuria and other inherited metabolic disease.J. Inher. Metab. Dis. 5 Suppl 2 (1982) 75–81

    PubMed  Google Scholar 

  • Prensky, A. L., Carr, S. and Moser, H. W. Development of myelin in inherited disorders of amino acid metabolism.Arch. Neurol. 19 (1968) 552–558

    PubMed  Google Scholar 

  • Seashore, M. R., Friedman, E., Novelly, R. A. and Bapat, V. Loss of intellectual function in children with phenylketonuria after relaxation of dietary phenylalanine restriction.Pediatrics 75 (1985) 226–232

    PubMed  Google Scholar 

  • Seifert, W. E., Foxx, J. L. and Butler, I. J. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.Ann. Neurol. 8 (1980) 38–42

    PubMed  Google Scholar 

  • Smith, I., Lobascher, M. E., Stevenson, J. E., Wolff, O. H., Schmidt, H., Grubel-Kaiser, S. and Bickel, H. Effect of stopping low-phenylalanine diet on intellectual progress of children with phenylketonuria.Br. Med. J. 2 (1978) 723–726

    PubMed  Google Scholar 

  • Waisbren, S. E., Mahon, B. E., Schnell, R. R. and Levy, M. L. Predictors of intelligence quotient and intelligence quotient change in persons located for phenylketonuria early in life.Pediatrics 79 (1987) 351–355

    PubMed  Google Scholar 

  • Williamson, M. D., Koch, R. and Berlow, S. Diet discontinuation in phenylketonuria.Pediatrics 63 (1979) 823–824

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Rights and permissions

Reprints and Permissions

About this article

Cite this article

Villasana, D., Butler, I.J., Williams, J.C. et al. Neurological deterioration in adult phenylketonuria. J Inherit Metab Dis 12, 451–457 (1989).

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI:


  • Neurological Deterioration
  • Biogenic Amine
  • Seizure Frequency
  • Phenylketonuria
  • Increase Signal Intensity